About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 848 record(s)
Req # A-2023-000483
A list of every drug approved under Health Canada's Special Access Program (SAP) between January 1, 2018 and July 6, 2023.Organization: Health Canada
January 2024
Req # A-2023-000968
Information on the intended use of a device listed on Medical Device Active License Listing (MDALL). Requesting it for the following: Licence No.: 95942, Type: System, Device class: 2, Device first issue date 2015-10-15, Licence name: VIASURE, Device first issue date: 2015-10-15, Device name: OW100 - APPLICATORS, Identifier first issue date: 2015-10-15, Device identifiers: OE035, OE050, OP155 and Device first issue date: 2021-08-05, Device name - VIASURE, Identifier first issue date: 2021-08-05, Device identifiers: 1000017.Organization: Health Canada
January 2024
Req # A-2023-000675
Adverse Drug Reactions (ADRs) for ZOSTAVAX II. Report numbers: E2B_02229369, E2B_02381693, E2B_02396904, E2B_02504551, E2B_01438894, E2B_02504551, E2B_02381693, E2B_02760591, E2B_02511273, E2B_01497636.Organization: Health Canada
December 2023
Req # A-2023-000858
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-106744-816, Upcoming Publication of Proposed and Final Post-Market Decisions for Pesticides.Organization: Health Canada
December 2023
Req # A-2023-001050
A report showing the total amount spent on office furniture by your department/agency by calendar year, as well as a report listing each transaction within each year showing Date, Transaction number, General Leger (GL) Account, GL description, Text field, and Amount. For calendar years of 2020, 2021, and 2022. Provide annual totals for those years.Organization: Health Canada
December 2023
Req # A-2023-001053
A report showing the total amount spent by your agency/department by calendar year, as well as a report listing each transaction within each year showing Date, Transaction number, General Leger (GL) Account, GL description, Text field, and Amount on office equipment to facilitate employees working from home. Limit search to the calendar years of 2020, 2021 and 2022. Provide annual totals for those years.Organization: Health Canada
December 2023
Req # A-2023-001060
The list of all the companies that reported their tobacco sales and ingredients to Health Canada for the year of 2022.Organization: Health Canada
December 2023
Req # A-2023-000806
The total amounts expended for advertising related to COVID-19 awareness from June 1, 2020 to December 31, 2022. The list of advertising expenditures incurred by the Department during the 2020/21, 2021/22 and 2022/23 fiscal years on a monthly basis for the same reason during the same period.Organization: Health Canada
November 2023
Req # A-2023-000943
A list of closed legal cases that involved a drug or medical device where Health Canada was named as a defendant dating back to 2000.Organization: Health Canada
November 2023
Req # A-2023-000946
List of active legal cases that involve a drug or medical device where Health Canada is named as a defendant.Organization: Health Canada
November 2023